AzTrials
AzTrials

PneumoniaNCT04114331

Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head Posture

A study testing Manual therapy and exercise in people with Pneumonia and COPD, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately… Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Pneumonia, COPD, Hyperkyphosis
What is being tested?
Manual therapy and exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
26 Feb 2018to 20 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • at least 50 years of age
  • hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD)
  • community dwelling
  • self report of ability to walk 10 feet or greater with or without an assistive device
  • ability to perform informed consent
  • ability to transport to research facility
  • ability to read and write in English or Spanish

Who cannot join

  • Inability to perform informed consent
  • Inability to follow directions
  • Inability to perform transfers, sit, and stand independently
  • Inability to ambulate 10 feet or more with or without an assistive device
  • Inability to perform pulmonary function testing
  • Inability to fully participate in testing and measures
Show all 14Show fewer
  • Inability to fully participate in the intervention
  • Severe claustrophobia
  • Unable to tolerate physical touch
  • Morbid obesity (BMI greater than 40)
  • History of prior lung disease such as cancer or transplant
  • History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA).
  • A prior discharge within 30 days of hospitalization for pneumonia or COPD
  • Discharge against medical advice

Trial locations and contacts

1 site in 1 country.

United States1 site
  • School of Health Professions at the University of Texas Medical Branch

    Galveston, Texas, 77555-1144

Other trials in United States

About this study

Official title: Feasibility of a Post-Hospitalization PT Intervention in Patients With Pneumonia

The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.

Read the detailed description

This original study was a feasibility study to determine the ability to recruit and to assess pilot data to determine the effects of a physical therapy intervention on physical function, gait, balance, posture, pulmonary function, and quality of life. Additionally the 30 day readmission, ER visits, and mortality was to be tracked. This study failed due to lack of recruitment. However, the aim to examine the effectiveness a physical therapy intervention was still used just in a broader population. The intervention and measures remained the same except for 30 day admission/mortality data.

The new aim was to examine the effectiveness of manual therapy and exercise on posture, function, gait, pulmonary function, and quality of life in older community dwelling adults with hyperkyphosis or forward head posture. Kyphosis, osteoporosis, decreased trunk flexibility, and pain are considered potential causes of restrictive lung function. The physical therapy intervention targets both soft tissue and skeletal restrictions to improve mobility. The outcomes were chosen to examine not only the direct impact on posture but also the indirect impact on physical function including pulmonary status. Lastly, cognitive mapping was used to record the change in the perceptions of the participants as they improved.

Being tested
Manual therapy and exercise
Keywords
forward head posture
Medical subject headings
Pneumonia, Pulmonary Disease, Chronic Obstructive, Kyphosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual therapy and exerciseOther

    Manual therapy consisting of soft tissue and joint mobilization to gain mobility. Therapeutic exercise was active motion and resisted motion to gain motor control and motor coordination in the new range.

Study groups in NCT04114331
Study groupRoleWhat they receive
Manual therapy and exerciseExperimentalThe intervention (3 times a week for 4 weeks, for a total of 12 sessions) consisted primarily of manual therapy (soft tissue and joint mobilization) followed by therapeutic exercises (muscular control and coordination). Manual therapy: Joint mobilizations (Grades I-V) to cervical spine, thoracic spine and ribs Soft tissue mobilization to the pectoralis, scaleni, upper traps, thoracolumbar fascia, erector spinae, and suboccipital musculature Therapeutic exercises: Strengthening of mid and lower traps, lats, glut med, and glut max. Active \& passive stretching of thoracic and lumbar rotation, hip flexors, and plantarflexors. The treating therapists agreed on a protocol with treatment individualized to each patient.
Receives: Other: Manual therapy and exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Posture, as measured by change in height

    Height in cm

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  2. Posture, as measured by change in kyphotic index

    kyphotic index = (thoracic width/thoracic height) *100 as measured from flexicurve tracing. A flexible ruler is molded to the posterior spine from C7 to the lumbosacral interspace. Ruler is placed on paper and traced. Measures of the thoracic width and height are taken in centimeters.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  3. Posture, as measured by change in block test

    height of blocks (measured in cm) under the head with participant supine

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  4. Posture, visual change in digital photos

    Digital photo in standing anterior and side views as well as supine view

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

Secondary outcomes (9)
  1. Function as a change in Timed Up and Go speed

    Timed Up and Go as measured in seconds to performed standardized functional test. Participants are timed in seconds from sitting in a chair to standing, walking 3 meters, turning around, walking back, and sitting down.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  2. Function as a change in Functional Reach test

    Functional reach as measured in cm. It is performed by having the participant standing still and is instructed to reach forward as far as you can without taking a step.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  3. Function as a change in the Short Physical Performance Battery (SPPB) score

    SPPB score as determined by seconds to perform each component of this standardized test. This functional test has 3 components of 5 times sit to stand, gait speed, and balance. 5 times sit to stand is a standardized test of lower extremity strength that is performed by rising and sitting in a chair 5 times in a row. The activity is timed. Gait speed will be extracted from gaitrite data. Balance tests will be timed.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  4. Function and Gait as a change in the 2 Minute Walk Test (2MWT)

    2MWT is the measured as the distance (feet) covered in 2 minutes

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  5. Function and patient perception as change in the Patient Specific Functional Scale (PSFS)

    PSFS is a standardized survey of activities that are difficult to perform (listed by participant) and to what degree as measured on a likert scale (0 to 10)

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  6. Gait as measured by change in gait parameters on a Gaitrite walkway

    The gaitrite records a standard set of parameters. Change in gait speed (m/sec), step length (cm), stride length (cm), double limb support time (seconds), and step width (cm)

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  7. Gait as measured by change in Tekscan measures of force

    Tekscan records a standard set of measures of time and force. Change in peak force at loading response, mid-stance, and terminal stance in newtons.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  8. Pulmonary function change measure by spirometry

    Spirometry provides standard measures of respiratory volume and volume in time. Changes in Forced Vital Capacity and Forced Expiratory Volume in 1 second were the measures of interest.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

  9. Patient perception as measured by changes in Cognitive Mapping

    Cognitive mapping provides the issues, concerns, and perceptions of the participants of how posture affects their life. Measured by words recorded and qualitative analysis.

    Measured: through study completion (4 weeks) and one time follow-up at an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2019
  2. Study start26 Feb 2018
  3. Primary completion18 Apr 2019
  4. Study completion20 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04114331
Sponsor's protocol ID
15-0098
Status last verified
Aug 2019
First submitted
16 Sep 2019
Last updated
5 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Hughes LC, Ellis AL, Rogers HL, Hadley M, Galloway RV. A secondary analysis of gait after a 4-week postural intervention for older adults with hyperkyphosis. BMC Musculoskelet Disord. 2025 Feb 11;26(1):136. doi: 10.1186/s12891-025-08330-7.

    PubMed 39934800
  • Hughes LC, Galloway RV, Fisher SR. Feasibility of a 4-Week Manual Therapy and Exercise Intervention on Posture and Function in Community-Dwelling Older Adults: A Pilot Study. J Geriatr Phys Ther. 2022 Jul-Sep 01;46(3):151-160. doi: 10.1519/JPT.0000000000000360. Epub 2022 Aug 5.

    PubMed 35939663

Questions about this trial

What is this clinical trial studying?

A study testing Manual therapy and exercise in people with Pneumonia and COPD, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Posture, as measured by change in height (time frame: through study completion (4 weeks) and one time follow-up at an average of 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04114331, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in